A pooled analysis of interval cancer rates in six European countries

European Journal of Cancer Prevention

Volumn 19, Issue 2, 2010, Pages 87-93

  Törnberg, Sven ^a   Kemetli, Levent ^a   Ascunce, Nieves ^a   Hofvind, Solveig ^a   Anttila, Ahti ^a   Sèradour, Brigitte ^a   Paci, Eugenio ^a   Guldenfels, Cathrine ^a   Azavedo, Edward ^a   Frigerio, Alfonso ^a   Rodrigues, Vitor ^a   Ponti, Antonio ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Interval cancer; Mammography screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; EUROPE; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT PARTICIPATION; REGISTRIES; TIME FACTORS;

EID: 76449091663     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833548ed     Document Type: Article

References (47)

1. Asbury D, Boggis CR, Sheals D, Threlfall AG,Woodman CB (1996). NHS breast screening programme: is the high incidence of interval cancers inevitable? BMJ 313:1369-1370.
2. Ascunce N, del Moral A, Murillo A, Alfaro C, Apesteguia L, Ros J, et al. (1994). Early detection programme for breast cancer in Navarra, Spain. Eur J Cancer Prev 3 (Suppl 1):41-48.
3. Barlow L, Westergren K, Holmberg L, Talback M (2009). The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 48:27-33.
4. Blanks RG, Moss SM (1996). Monitoring the performance of breast screening programmes: allowing for geographical variation in breast cancer incidence. J Med Screen 3:82-84.
5. Bray F, Sankila R, Ferlay J, Parkin DM (2002). Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99-166. (Pubitemid 34031832)
6. Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ (1996). Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer 78:1220-1228.
7. Brown M, Eccles C, Wallis MG (2001). Geographical distribution of breast cancers on the mammogram: an interval cancer database. Br J Radiol 74:317-322.
8. Bucchi L, Puliti D, Ravaioli A, Cortesi L, De Lisi V, Falcini F, et al. (2008a). Breast screening: axillary lymph node status of interval cancers by interval year. Breast 17:477-483.
9. Bucchi L, Ravaioli A, Foca F, Colamartini A, Falcini F, Naldoni C (2008b). Incidence of interval breast cancers after 650 000 negative mammographies in 13 Italian health districts. J Med Screen 15:30-35.
10. Bulliard JL, Sasieni P, Klabunde C, De Landtsheer JP, Yankaskas BC, Fracheboud J (2006). Methodological issues in international comparison of interval breast cancers. Int J Cancer 119:1158-1163.
11. Cuzick J, Edwards R, Segnan N (1997). Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 16:1017-1029.
12. Day N, McCann J, Camilleri-Ferrante C, Britton P, Hurst G, Cush S, Duffy S (1995). Monitoring interval cancers in breast screening programmes: the East Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme. J Med Screen 2:180-185.
13. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998). Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338:1089-1096.
14. Everington D, Gilbert FJ, Tyack C,Warner J (1999). The Scottish breast screening programme's experience of monitoring interval cancers. J MedScreen 6:21-27.
15. Exbrayat C, Garnier A, Colonna M, Assouline D, Salicru B,Winckel P, et al. (1999). Analysis and classification of interval cancers in a French breast cancer screening programme (department of Isere). Eur J Cancer Prev 8:255-260.
16. Faux AM, Richardson DC, Lawrence GM, Wheaton ME, Wallis MG (1997). Interval breast cancers in the NHS breast screening programme: does the current definition exclude too many? J Med Screen 4:169-173.
17. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Hendriks JH, Verbeek AL, et al. (1998). Nation-wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 75:694-698.
18. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, et al. (1999). Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 81:912-917.
19. Frisell J, Eklund G, Hellstrom L, Somell A (1987). Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 9:219-225.
20. Goel A, Littenberg B, Burack RC (2007). The association between the prediagnosis mammography screening interval and advanced breast cancer. Breast Cancer Res Treat 102:339-345.
21. Gorini G, Zappa M, Miccinesi G, Paci E, Costantini AS, Falini P, et al. (2004). Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s. Br J Cancer 90:1780-1783.
22. Hofvind S, Thoresen S, Tretli S (2004). The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 101:1501-1507.
23. Hofvind S, Bjurstam N, Sorum R, Bjorndal H, Thoresen S, Skaane P (2006). Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme. J Med Screen 13:192-196.
24. IARC (2002). Cancer Incidence in Five Continents, Vol.VIII. Lyon: IARC Scientific Publications No. 155.
25. Johnson AE, Shekhdar J (1995). Interval cancers in the National Health Service Breast Screening Programme. Br J Radiol 68:862-869.
26. Kavanagh AM, Mitchell H, Farrugia H, Giles GG (1999). Monitoring interval cancers in an Australian mammographic screening programme. J Med Screen 6:139-143.
27. Klemi PJ, Toikkanen S, Rasanen O, Parvinen I, Joensuu H (1997). Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer 75:762-766.
28. Lynge E (1998). Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. APMIS Suppl 83:1-44.
29. Mattsson B,Wallgren A (1984). Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23:305-313.
30. McCann J,Wait S, Seradour B, Day N (1997). A comparison of the performance and impact of breast cancer screening programmes in East Anglia, U.K. and Bouches du Rhone, France. Eur J Cancer 33:429-435.
31. Moberg K, Grundstrom H, Tornberg S, Lundquist H, Svane G, Havervall L, Muren C (1999). Two models for radiological reviewing of interval cancers. J Med Screen 6:35-39.
32. Moss S, Blanks R (1998). Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group. J Epidemiol Community Health 52:111-115.
33. Newcombe RG (1998). Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857-872.
34. Otten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, et al. (2005). Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 97: 748-754.
35. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. (2006). European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: European Commission.
36. Renaud R, Gairard B, Schaffer P, Guldenfels C, Haehnel P, Dale G, Bellocq JP (1994). Europe against cancer breast cancer screening programme in France: the ADEMAS programme in Bas-Rhin. Eur J Cancer Prev 3 (Suppl 1):13-19.
37. Rickard MT, Taylor RJ, Fazli MA, El Hassan N (1998). Interval breast cancers in an Australian mammographic screening program. Med J Aust 169:184-187.
38. Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A (2006). Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 118:174-179.
39. Sylvester PA, Kutt E, Baird A, Vipond MN, Webb AJ, Farndon JR (1997a). Rate and classification of interval cancers in the breast screening programme. Ann R Coll Surg Engl 79:276-277.
40. Sylvester PA, Vipond MN, Kutt E, Davies JD, Webb AJ, Farndon JR (1997b). A comparative audit of prevalent, incident and interval cancers in the Avon breast screening programme. Ann R Coll Surg Engl 79:272-275.
41. Tabar L, Faberberg G, Day NE, Holmberg L (1987). What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55:547-551.
42. Taylor R, Supramaniam R, Rickard M, Estoesta J, Moreira C (2002). Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes. J Med Screen 9:20-25.
43. Törnberg S, Codd M, Rodrigues V, Segnan N, Ponti A (2005). Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen 12:43-49.
44. Warren R, Duffy S (2000). Interval cancers as an indicator of performance in breast screening. Breast Cancer 7:9-18.
45. Woodman CB, Threlfall AG, Boggis CR, Prior P (1995). Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 310:224-226.
46. Yankaskas BC, Klabunde CN, Ancelle-Park R, Renner G,Wang H, Fracheboud J, et al. (2004). International comparison of performance measures for screening mammography: can it be done? J Med Screen 11:187-193.
47. Zappa M, Falini P, Bonardi R, Ambrogetti D, Giorgi D, Paci E, Ciatto S (2002). Monitoring interval cancers in mammographic screening: the Florence District programme experience. Breast 11:301-305. (Pubitemid 35174946)